Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial

Insulin Lung Deposition and Clearance Following Technosphere® Insulin Inhalation Powder Administration

(2011) James P. Cassidy et al.   PHARMACEUTICAL RESEARCH

Pulmonary Function in Diabetes

(2010) Bram van den Borst et al.   CHEST

Systematic review of the association between lung function and Type 2 diabetes mellitus

(2010) O. L. Klein et al.   DIABETIC MEDICINE

Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial

(2010) Julio Rosenstock et al.   LANCET

Safety and Efficacy of Inhaled Human Insulin (Exubera) During Discontinuation and Readministration of Therapy in Adults with Type 2 Diabetes: A 3-Year Randomized Controlled Trial

(2009) Julio Rosenstock et al.   Diabetes Technology & Therapeutics

Two-Year Pulmonary Safety and Efficacy of Inhaled Human Insulin (Exubera) in Adult Patients With Type 2 Diabetes

(2008) J. Rosenstock et al.   DIABETES CARE

Safety and efficacy of inhaled human insulin (Exubera®) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial

(2008) Jay S. Skyler et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Effects of inhaled human insulin on airway lining fluid composition in adults with diabetes

(2008) M. C. Liu et al.   EUROPEAN RESPIRATORY JOURNAL